ACTION MEDICAL RESEARCH — grant history
Latest income
£7.8m
Grants listed (FY2025)
15
Listed grants total
£3.2m
Accounts grants total
£3.0m
listed grants reconcile with the accounts totalextracted from its FY2025 accounts
What changed: FY2024 → FY2025
| Change | Grantee | FY2024 | FY2025 |
|---|---|---|---|
| new | Royal Hospital for Children, Glasgow, Department of Paediatric Endocrinology | — | £298k |
| new | University College London, Institute of Child Health | — | £275k |
| new | University of Oxford Department of Paediatrics | — | £275k |
| new | King’s College London, School of Life Course and Population Sciences | — | £245k |
| new | University College London, Developmental Biology and Cancer | — | £240k |
| new | University College London, Institute for Women’s Health | — | £200k |
| new | University College London, Institute of Ophthalmology | — | £200k |
| new | Queen’s University Belfast Northern Ireland Clinical Research Facility | — | £200k |
| not listed | Translational & Clinical Research Institute Newcastle University | £275k | — |
| not listed | Paediatric Neuroimaging Group Oxford University | £275k | — |
| not listed | Centre for Perinatal Research Queen Mary Medical Centre Nottingham | £275k | — |
| not listed | Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham; Department of Endocrinology, Birmingham Women’s and Children’s Hospital | £250k | — |
| not listed | Centre for Adolescent Rheumatology University College London | £243k | — |
| not listed | University of Cambridge Department for Paediatrics | £200k | — |
| not listed | St Mary University Hospital Department of Surgery and Cancer | £200k | — |
| not listed | King’s College London Department of Perinatal Imaging and Health | £200k | — |
Grants made, per its accounts filings
| Recipient | Year | Amount | Purpose |
|---|---|---|---|
| Royal Hospital for Children, Glasgow, Department of Paediatric Endocrinology | FY2025 | £298k | Duchenne Muscular Dystrophy: Creating a Tool to Predict Spine Fractures in Young People with DMD |
| University College London, Institute of Child Health | FY2025 | £275k | Rasmussen’s Encephalitis: Uncovering early signs and underlying causes of a rare childhood epilepsy with innovative scientific method |
| University of Oxford Department of Paediatrics | FY2025 | £275k | Post-operative pain: Improving the assessment of pain in infants after surgery |
| King’s College London, School of Life Course and Population Sciences | FY2025 | £245k | Preterm birth: Developing cell therapy to treat preterm birth |
| University College London, Developmental Biology and Cancer | FY2025 | £240k | Preterm birth: Understanding the link with fetal anomalies |
| University College London, Institute for Women’s Health | FY2025 | £200k | Brain injury at birth: Can melatonin or cooling help in cases of mild newborn brain injury? |
| University College London, Institute of Ophthalmology | FY2025 | £200k | Blindness: discovering new therapies for optic atrophy |
| Queen’s University Belfast Northern Ireland Clinical Research Facility | FY2025 | £200k | Preventing vision loss by testing strategies to improve glasses wear in children with learning disabilities |
| Newcastle University Centre for Cancer Wolfson Childhood Cancer Research Centre | FY2025 | £200k | T-cell Acute Lymphoblastic Leukaemia: Laboratory testing of new blockers of TALL survival |
| Birmingham Women’s and Children’s NHS Foundation Trust | FY2025 | £200k | Polycystic Ovarian Syndrome (PCOS): A feasibility trial to help design a definitive clinical trial to test the effectiveness of myo-inositol as a treatment for adolescent PCOS |
| University College London Great Ormond Street Institute of Child Health | FY2025 | £200k | Non-Ketotic Hyperglycinemia (NKH): developing new treatments for life limiting inherited metabolic disease |
| University College London | FY2025 | £199k | Viral respiratory infections: finding effective treatment for vulnerable children |
| Imperial College London, Department of CF and Chronic Lung Infection, National Heart and Lung Institute | FY2025 | £199k | Cystic Fibrosis: Understanding outcomes for children with an inconclusive diagnosis of CFSPID |
| University College London, Department of Neuroscience, Physiology and Pharmacology | FY2025 | £198k | Cystic fibrosis: Developing new drug treatments to improve patient outcomes |
| University of Cambridge Cambridge Universities Hospitals NHS Foundation Trust | FY2025 | £115k | Brain injury in newborn babies: improving prediction and diagnosis through a new cot side brain scanner |
| Translational & Clinical Research Institute Newcastle University | FY2024 | £275k | Inborn errors of immunity: improving the outcomes of stem cell transplantation |
| Paediatric Neuroimaging Group Oxford University | FY2024 | £275k | Improving Outcomes from Premature Babies: Can gentle touch reduce pain? |
| Centre for Perinatal Research Queen Mary Medical Centre Nottingham | FY2024 | £275k | Reducing infections from breathing tubes in premature babies |
| Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham; Department of Endocrinology, Birmingham Women’s and Children’s Hospital | FY2024 | £250k | New treatments for rare childhood onset neurological diseases, Niemann-Pick type C1 disease and Wolfram syndrome |
| Centre for Adolescent Rheumatology University College London | FY2024 | £243k | Juvenile systemic lupus erythematosus (JSLE): identifying children at risk of cardiovascular disease |
| University of Cambridge Department for Paediatrics | FY2024 | £200k | Ventilator-associated pneumonia (VAP): Developing a tool to predict lung infections in children who are critically ill |
| St Mary University Hospital Department of Surgery and Cancer | FY2024 | £200k | Respiratory infections: Developing a novel non-invasive breath test to diagnose bacterial chest infections in critically ill children |
| King’s College London Department of Perinatal Imaging and Health | FY2024 | £200k | Neurodevelopmental conditions: A new way to understand social brain processing in autism by combining MRI scanning and virtual reality |
| Zayed Centre for Rare Disease Research University College London | FY2024 | £200k | Epilepsy: Putting the brake on sodium channels |
| King’s College London Department of Psychology | FY2024 | £197k | Epilepsy: Identifying early life predictors of later neurodevelopmental outcomes |
| Royal Veterinary College Department of Comparative Biological Sciences | FY2024 | £196k | Preterm birth: Preventing brain injury with a novel therapy |
| Newcastle University School of Pharmacy | FY2024 | £177k | Cystinosis: engineering new forms of cysteamine to improve palatability and shelf life |
| University College London Great Ormond Street Institute of Child Health | FY2024 | £175k | Histone deacetylase inhibitors and oligonucleotide antisense double treatment for DMD |
| University of Exeter Department of Clinical and Biomedical Sciences | FY2024 | £129k | Developing an effective treatment for neurofibromatosis type 1 |
| National Heart and Lung Institute, Imperial College London and Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London | FY2023 | £268k | Research Training Fellowship at the National Heart and Lung Institute, Imperial College London and Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London |
| Centre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital; Molecular and Clinical Sciences Research Institute, St George’s University of London | FY2023 | £250k | Research Training Fellowship at the Centre for Paediatric Inherited and Rare Cardiovascular Disease |
| Medicines Discovery Institute and School of Biosciences, Cardiff University | FY2023 | £250k | Developing non-covalent acid ceramidase inhibitors to treat Krabbe disease |
| Dyson School of Design Engineering, Imperial College London; Department of Respiratory Medicine, Sheffield Children’s NHS Foundation Trust | FY2023 | £249k | Overcoming craniofacial abnormalities: Establishing a digital mass customisation design-through-manufacture pipeline for facemasks for children using non-invasive ventilation (NIV) |
| Department of Women’s and Children’s Health, St Thomas’ Hospital, King’s College London | FY2023 | £247k | A randomised controlled trial to assess the optimal management of preterm birth risk secondary to C-section damage |
| Department of Surgical and Interventional Engineering and School of Cancer and Pharmaceutical Sciences, King’s College London | FY2023 | £246k | Targeted gene therapy in diffuse midline glioma using focused ultrasound |
| Department of Maternal and Fetal Medicine, EGA Institute for Women’s Health, University College London | FY2023 | £245k | Cervical human beta defensin 2 (HBD2) gene therapy for the prevention of infection-associated preterm birth and neonatal morbidity |
| Bristol Medical School, University of Bristol | FY2023 | £242k | Generation of personalised Glomspheres from patients with inherited nephrotic syndromes, to repurpose and discover compounds to rescue the disease phenotype |
| Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, Department of Cell and Developmental Biology and Department of Neuroscience, Physiology and Pharmacology, University College London; MRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, King’s College London | FY2023 | £200k | Understanding the role of vitamin B6 dyshomeostasis in epilepsy disorders |
| Centre for Cell Biology and Cutaneous Research and the School of Engineering and Materials Science, Queen Mary University of London and the Institute of Inflammation and Ageing, University of Birmingham | FY2023 | £200k | Targeting epigenetic gene regulation in epidermolysis bullosa simplex |
| Department of Genetics and Genomic Medicine and Infection Immunity Inflammation, UCL Great Ormond Street Institute of Child Health, University College London; UCL Elizabeth Garrett Anderson Institute for Women’s Health and Division of Surgery and Interventional Science, University College London | FY2023 | £184k | Development of lentiviral in vivo gene therapy for Progressive Familial Intrahepatic Cholestasis type 3 |
| University of Edinburgh, Centre for Genomic and Experimental Medicine, Western General Hospital | FY2023 | £155k | Preclinical testing of allele-specific antisense oligonucleotide (ASO) therapy for a rare neurodevelopmental disorder caused by mutations in EEF1A2 |
| Department of Electronic and Electrical Engineering, Swansea University and the Division of Infection and Immunity, School of Medicine, Cardiff University | FY2023 | £57k | Development of printed biosensors for screening of human cytomegalovirus (HCMV) in newborn babies |
| Radcliffe Department of Medicine, Nuffield Division of Clinical Laboratory Sciences, University of Oxford. | FY2022 | £272k | Lung disease in babies developing gene therapy for lung surfactant deficiency |
| Research Training Fellowship at the Department of Clinical Neurosciences, University of Cambridge and the Department of Paediatric Neurology, Child Development Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust. | FY2022 | £250k | Multiple sclerosis - assessing brain repair in children |
| Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology and the Department of Neuroscience, Physiology and Pharmacology, University College London. | FY2022 | £248k | Epilepsy – gene therapy for severe childhood epilepsy |
| Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London. | FY2022 | £246k | Brain cancer – developing immunotherapy for medulloblastoma and high-grade glioma |
| Human Genetics, Wellcome Sanger Institute, Cambridge and the Department of Paediatrics, Addenbrooke's Hospital, University of Cambridge. | FY2022 | £229k | Developmental disorders – improving genetic diagnosis |
| Department of Metabolism, Digestion and Reproduction, Chelsea and Westminster Hospital Campus, Imperial College London. | FY2022 | £205k | Preterm birth – understanding how labour begins |
| Department of Cell and Developmental Biology, University College London. | FY2022 | £199k | Vici syndrome – developing a potential new drug treatment |
| Research Training Fellowship at the Centre for Perinatal Research, School of Medicine and School of Computer Science, University of Nottingham. | FY2022 | £195k | Premature babies – developing a clinical prediction tool to guide treatment decisions |
| Research Training Fellowship at the Reconstructive Surgery and Regenerative Medicine Research Centre and In Vitro Toxicology Group, Swansea University Medical School, Swansea University. | FY2022 | £189k | Facial disfigurement – investigating the safety and biocompatibility of novel implants |
| MRC Lifecourse Epidemiology Centre, NIHR BRC-supported Clinical Metabolomics Unit, University of Southampton; Paediatric Endocrinology, University Hospital Southampton NHS Foundation Trust. | FY2022 | £187k | Vitamin D supplementation during pregnancy and child health |
| Infection, Immunity and Inflammation Research & Teaching Department, Primary ciliary dyskinesia – restoring ciliary function Genetics and Genomic Medicine Research and Teaching Department, Regenerative Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London; Respiratory Sciences, University of Leicester. | FY2022 | £172k | Primary ciliary dyskinesia – restoring ciliary function |
| Developmental Neurosciences and Developmental Biology and Cancer, UCL Great Ormond Street Institute of Child Health, University College London; Computer Science, University College London; Department of Neurosurgery, Great Ormond Street Hospital, London. | FY2022 | £124k | Epilepsy – investigating a new imaging technique to detect brain lesions |
| School of Biomedical Engineering and Imaging Sciences, King's College London; Pediatric Cardiology Department, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds. | FY2022 | £64k | Congenital heart disease – predicting the outcome of surgical reconstruction of the aorta |